Amitriptyline vs Duloxetine
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Amitriptyline and duloxetine (Cymbalta) are both antidepressants commonly used for pain management, particularly neuropathic pain and fibromyalgia [1][2]. Despite both affecting serotonin and norepinephrine, they belong to different drug classes with distinct side effect profiles.
Amitriptyline is a tricyclic antidepressant (TCA) that was introduced in the 1960s [1]. It inhibits serotonin and norepinephrine reuptake but also has significant anticholinergic, antihistaminic, and alpha-adrenergic blocking effects that contribute to its broad side effect profile [1].
Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved in 2004 with a more targeted mechanism [2]. It has FDA approvals for MDD, GAD, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain [2].
Amitriptyline vs Duloxetine: Side-by-side comparison
| Category | Amitriptyline | Duloxetine |
|---|---|---|
| Drug Class | Tricyclic antidepressant (TCA) | Serotonin-norepinephrine reuptake inhibitor (SNRI) |
| Generic Name | Amitriptyline HCl | Duloxetine HCl |
| Brand Name | Elavil (discontinued) | Cymbalta |
| FDA Approved For | Depression (also widely used off-label for pain) | MDD, GAD, diabetic neuropathy, fibromyalgia, chronic pain |
| How It Works | Inhibits serotonin/NE reuptake + anticholinergic, antihistamine effects | Selectively inhibits serotonin and norepinephrine reuptake |
| Dosage Forms | Tablets (10-150 mg) | Delayed-release capsules (20, 30, 60 mg) |
| Typical Dose | 25-75 mg at bedtime (pain); 100-150 mg (depression) | 60 mg once daily |
| Common Side Effects | Sedation, dry mouth, constipation, weight gain, blurred vision | Nausea, dry mouth, constipation, fatigue, insomnia |
| Sedation Level | High | Low-moderate |
| Weight Effect | Weight gain (2-5 kg) | Generally weight-neutral |
| Overdose Safety | Dangerous (cardiac toxicity) | Relatively safe |
| Cost (Generic) | $4-$10/month | $8-$20/month |
Efficacy: How well does each drug work?
For neuropathic pain, both medications are recommended by the AAN and international guidelines [3]. Amitriptyline has decades of evidence for neuropathic pain management, with NNT (number needed to treat) of approximately 3-4 for 50% pain reduction [3]. Duloxetine has demonstrated similar efficacy in diabetic neuropathy trials (NNT ~5-6) [2][3].
For fibromyalgia, duloxetine is FDA-approved and has robust randomized trial evidence [2]. Amitriptyline is widely used off-label for fibromyalgia with good evidence supporting its use, particularly at low doses (10-50 mg) [1].
For depression, duloxetine is generally preferred as a first-line treatment due to its cleaner side effect profile [2]. Amitriptyline is effective but rarely used as a first-line antidepressant due to its side effects and toxicity in overdose [1].
For migraine prevention, amitriptyline has Level A evidence and is one of the most commonly used preventive medications [1]. Duloxetine does not have this indication.
Side effects comparison
Amitriptyline's broad receptor activity produces numerous side effects: sedation (strong antihistamine effect), dry mouth, constipation, urinary retention, blurred vision (anticholinergic effects), weight gain (average 2-5 kg), orthostatic hypotension, and cardiac conduction effects (QTc prolongation, risk of arrhythmia in overdose) [1]. It is dangerous in overdose — a major concern given it is prescribed for depression [1].
Duloxetine's more selective mechanism produces fewer side effects: nausea (24%), dry mouth (13%), constipation (10%), fatigue (10%), decreased appetite, and insomnia [2]. Sexual dysfunction occurs but at lower rates than with some SSRIs. Duloxetine can increase blood pressure slightly and should not be used with severe hepatic impairment [2].
Duloxetine is significantly safer in overdose compared to amitriptyline [2]. Both can cause discontinuation syndrome if stopped abruptly — duloxetine is particularly notable for this and should be tapered gradually [2].
Cost comparison
Convenience and dosing
Amitriptyline is taken once daily, usually at bedtime to leverage its sedating properties for sleep [1]. Duloxetine is taken once or twice daily, typically in the morning due to its potential for insomnia [2]. Both are oral medications. Amitriptyline's sedation can be beneficial for patients with insomnia but problematic for daytime alertness. Duloxetine is less sedating and better for daytime function.
Which is right for you?
Duloxetine is generally preferred for most patients due to its cleaner side effect profile, better safety in overdose, and broader range of FDA-approved pain indications [2][3].
Amitriptyline may be preferred when sedation is desired (pain patients with insomnia), for migraine prevention, or when cost is the primary concern [1]. It should be used cautiously in elderly patients (anticholinergic burden), patients with cardiac conduction abnormalities, and patients at risk of self-harm [1].
For neuropathic pain specifically, some patients who do not respond to one will respond to the other — both remain important options in the pain management toolkit [3].
This information is for educational purposes only. Consult your healthcare provider for personalized treatment recommendations.
Frequently asked questions
References
- [Regulatory] Amitriptyline HCl prescribing information. FDA-approved labeling. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012703s084lbl.pdf Accessed 2025-06-15.
- [Regulatory] Duloxetine (Cymbalta) prescribing information. Eli Lilly. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021427s052lbl.pdf Accessed 2025-06-15.
- [Regulatory] Finnerup NB, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162-173. https://doi.org/10.1016/S1474-4422(14)70251-0 Accessed 2025-06-15.
- [Observational] GoodRx price comparison: amitriptyline and duloxetine. https://www.goodrx.com Accessed 2025-06-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: